Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Resectable Non–small Cell Lung Cancer Treated With Neoadjuvant Immunotherapy Plus Chemotherapy
The PERCIST is more accurate than iRECIST in evaluating prognosis for NSCLC neoadjuvant immunotherapy plus chemotherapy. PET metabolic parameters, particularly ΔSUVmax, effectively predict prognosis and support clinical decision-making.
Authors
- Zhen-Peng Jiang
- Xiaobo Chen (ORCID: https://orcid.org/0000-0001-8755-6199)
- Kai-yu Lu
- Dan Shao (ORCID: https://orcid.org/0000-0002-9925-0936)
- You Cheng (ORCID: https://orcid.org/0000-0002-9526-8629)
- Zaiyi Liu (ORCID: https://orcid.org/0000-0002-9307-8522)
Institutions
- Key Laboratory of Guangdong Province (CN)
- Guangzhou First People's Hospital (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
- South China University of Technology (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1097/rlu.0000000000005863
- Citations
- 6
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 8.16